Cause of death, by non-communicable diseases, ages 5-14, male in Rwanda
Rwanda: Cause of death, by non-communicable diseases, ages 5-14, male was 19.7% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Rwanda, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
Rwanda recorded 19.7% for cause of death, by non-communicable diseases, ages 5-14, male in 2021.
Compared with earlier readings it is down 0.4% on the previous year and up 40.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Rwanda peaked at 19.8% in 2020 and was at its lowest, 14.0%, in 2010.
Rwanda ranks 151st of 185 countries on this measure, in the bottom quarter.
Cause of death, by non-communicable diseases, ages 5-14, male in Rwanda, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 14.6% | — |
| 2010 | 14.0% | -4.3% |
| 2015 | 17.0% | +21.7% |
| 2019 | 19.4% | +13.7% |
| 2020 | 19.8% | +2.0% |
| 2021 | 19.7% | -0.4% |
Rwanda compared with similar countries
- Rwanda's 19.7% is above the median for low income countries, which is 18.9%, 1.0× the median. (25 countries reporting)
- Rwanda's 19.7% is above the median for Sub-Saharan Africa, which is 17.0%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.6% | 14.6% | 14.6% | 1 |
| 2010s | 16.8% | 14.0% | 19.4% | 3 |
| 2020s | 19.7% | 19.7% | 19.8% | 2 |
Countries ranked near Rwanda
More health data for Rwanda
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.891 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 860.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,738 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate 0.9441 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.065 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9697 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Rwanda?
- Cause of death, by non-communicable diseases, ages 5-14, male in Rwanda was 19.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Rwanda?
- The highest recorded value was 19.8% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Rwanda?
- The lowest recorded value was 14.0% in 2010.
- How does Rwanda rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Rwanda ranks 151st out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Rwanda?
- Over the last ten years it is up 40.4%. The long-run trend across the full record is rising.
- Where does this Rwanda data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.